— Diluted EPS of $3.77; Adjusted Diluted EPS1 of $3.67 —— Comparable Sales Decreased 4.3% —— Updates Full Year 2023 Outlook —
MOORESVILLE, N.C., May 23, 2023. | May 23, 2023
Net revenue of $562.4 million, an increase of 6.6% from Q1 2022
Comparable store sales growth of 3.0% and Adjusted Comparable Store Sales Growth of 0.8% from Q1 2022
Net income of $18.3. | May 11, 2023
Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases , which amended. | March 31, 2023
GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.